AMPK作为治疗2型糖尿病新靶点的研究进展

www.yongyao.net　　2009-8-18 10:55:04　　来源：　　责任编辑：

分享到：

参考文献:
[ 1 ] 　Kamysheva E P. Insulin resistance in internal diseases[ J ]. KlinM ed (M osk) , 2007, 85 (6) : 21 - 7.
[ 2 ] 　Blickle J F, Doucet J, Krummel T, et al. Diabetic nephr2opathy in the elderly[ J ]. D iabetesM etab, 2007, 33 (1) : 40 - 55.
[ 3 ] 　Scott JW, Ross F A, Liu J K, et al. Regulation ofAMP2activatedp rotein kinase by a p seudosubstrate sequence on the gamma subunit[ J ]. EMBO J, 2007, 26 (3) : 806 - 15.
[ 4 ] 　Stap leton D, Mitchelhill K I, Gao G, et al. Mammalian AMP2activated p rotein kinase subfamily[ J ]. J B iol Chem, 1996, 271 (2) :611 - 4.
[ 5 ] 　Hardie D G, Hawley S A, Scott J W. AMP2activated p rotein kinase2development of the energy sensor concep t [ J ]. J Physiol,2006, 574 (1) : 7 - 15.
[ 6 ] 　Schimmack G, Defronzo R A, MusiN. AMP2activated p rotein kinase: role in metabolism and therapeutic imp lications[ J ]. D iabetes ObesM etab, 2006, 8 (6) : 591 - 602.
[ 7 ] 　Tamas P, Hawley SA, Clarke R G, et a1. Regulation of the energy sensor AMP2activated p rotein kinase by antigen recep tor andCa2 + in T lymphocytes[ J ]. J Exp M ed, 2006, 203 ( 7) : 1665 -70.
[ 8 ] 　Cuthbertson D J, Babraj J A, Mustard K J, et al. 52aminoimidazole2 42carboxamide 12beta2D2ribofuranoside acutely stimulates skele2 talmuscle 22deoxyglucose up take in healthy men[ J ]. D iabetes, 2007, 56 (8) : 2078 - 84.
[ 9 ] 　Shaw R J, KosmatkaM,Bardeesy N, et a1. The tumor supp ressor LKB1 kinase directly activatesAMP2activated kinase and regulates apop tosis in response to energy stress [ J ]. Proc N atl Acad SciUSA, 2004, 101 (10) : 3329 - 35.
[ 10 ] XieM, Zhang D, Dyck J R, et al. A p ivotal role for endogenous TGF2β2activated kinase21 in the LKB1 /AMP2activated p rotein kinase energy2sensor pathway[ J ]. PNAS, 2006, 103 (46) : 17378 -83.
[ 11 ] Hawley SA, Pan D A, Mustard K J, et al. Calmodulin2dependentp rotein kinase kinase2β is an alternative up stream kinase forAMPactivated p rotein kinase[ J ]. CellM etab, 2005, 2 (1) : 9 - 19.
[ 12 ] Hardie D G. AMP2activated p rotein kinase as a drug target [ J ].Ann Rev Pharm acol Toxicol, 2007, 47: 185 - 210.
[ 13 ] Koo S H, FlechnerL, QiL, et al. The CREB coactivator TORCis a key regulator of fasting glucose metabolism [ J ]. N ature,2005, 437 (7062) : 1109 - 11.
[ 14 ] Mcgee S L, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 exp ression: Molecular mechanisms [ J ]. Clin ExpPharm acol Physiol, 2006, 33 (4) : 395 - 9.
[ 15 ] Wright D C, Geiger P C, HoHoszy J O, et a1. Contraction2and hypoxia 2stimulated glucose transport ismediated by a Ca2 + 2dependentmechanism in slow2twitch rat soleusmuscle[ J ]. Am J Physiol EndocrinolMetab, 2005, 288 (6) : 1062 - 6.
[ 16 ] 汪茂荣,李　蓉. AMPK与2型糖尿病关系研究进展[ J ]. 内分泌外科杂志, 2007, 1 (2) : 132 - 4.
[ 16 ] WangM R, Li R. Recent p rogress in the relationship of AMPK and type 2 diabetes[ J ]. J Endocrine Surg, 2007, 1 (2) : 132 - 4.
[ 17 ] Halse R, Fryer L G,McCormack J G, et a1. Regulation of glycogen synthase by glucose and glycogen: a possible role forAMP2active2 ated p rotein kinase[ J ]. D iabetes, 2003, 52 (1) : 9 - 15.
[ 18 ] ForetzM, Ancellin N, Andreelli F, et al. Shortterm overexp ression of a constitutively active form ofAMP2activated p rotein kinase in the liver leads to mild hypoglycemia and fatty liver[ J ]. D iabetes, 2005, 54 (5) : 1331 - 9.
[ 19 ] YoonM J,Lee G Y, Chung J J, et al. Adiponectin increases fattyacid oxidation in skeletal muscle cells by sequential activation of AMP2activated p rotein kinase, p38 mitogen2activated p rotein kinase, and peroxisome p rofiferator2activated recep tor alpha[ J ]. D iabetes, 2006, 55 (9) : 2562 - 70.
[ 20 ] 赵励彦,王莉莉,李　松. 脂肪酸合成酶抑制剂减肥作用机制的研究进展[ J ]. 中国药理学通报, 2006, 22 (7) : 780 - 4.
[ 20 ] Zhao L Y, Wang L L, Li S. Recent p rogress in weight reduction mechanism of inhibitor of fatty acid synthase[ J ]. Chin Pharm acolB ull, 2006, 22 (7) : 780 - 4.
[ 21 ] Kukidome D,Nishikawa T, Sonod K, et a1. Activation ofAMP2ac tivated p rotein kinase reduces hyperglycemia2induced mitochondrial reactive oxygen species p rodution and p romotesmitochondrial biogenesis in human umbilical vein endothelial cells[ J ]. D iabetes,2006, 55 (1) : 120 - 7.
[ 22 ] Folmes C D, Lopaschuk G D. Role of malonyl2CoA in heart disease and the hypothalamic control of obesity[ J ]. Cardiovasc Res,2007, 73 (2) : 278 - 87.
[ 23 ] 刘长锁,申竹芳. 游离脂肪酸与胰岛素抵抗[ J ]. 中国药理学通报, 2005, 21 (2) : 145 - 9.
[ 23 ] Liu C S, Shen Z F. Free fatty acid and insulin resistance [ J ].Chin Pharm acol B ull, 2005, 21 (2) : 145 - 9.
[ 24 ] Burcehn R, Criveili V, Perrin C, et a1. GLUT4,AMP kinase, butnot the insulin recep tor, are required for hepatoportal glucose sensor stimulated muscle glucose utilization[ J ]. J Clin Invest, 2003,111 (10) : 1555 - 62.
[ 25 ] Koistinen H A, GaluskaD, Chibalin A V, et a1. 52amino242imidazo2lecarboxamide ribonucleotide ( A ICAR ) increases glucose transport and cell surface GLUT4 content in skeletal muscle from subjectswith type 2 diabetes[ J ]. D iabetes, 2003, 52 (5) : lO66 -72.
[ 26 ] Steinberg G R, Jorgensen SB. The AMP2activated p rotein kinase:role in regulation of skeletal muscle metabolism and insulin sensitivity[ J ]. M ini RevMed Chem, 2007, 7 (5) : 519 - 26.
[ 27 ] Bloomgarden Z T. Insulin resistance, dyslip idemia, and cardiovascular disease[ J ]. D iabetes Care, 2007, 30 (8) : 2164 - 70.
[ 28 ] Buhl E S, Jessen N, Pold R, et al. Long2term A ICAR administration reduces metabolic disturbances and lowers blood p ressure inrats disp laying features of the insulin resistance syndrome[ J ]. D iabetes, 2002, 51 (7) : 2 l99 - 206.
[ 29 ] Atkinson L L, Kel1y S E, Russell J C, et a1. MED ICA 16 inhibits acetyl2CoA carboxylase and reduces p lasma triacylglycerol levels in insulin resistant JCR: LA2cp rats [ J ]. D iabetes, 2002, 51 ( 5 ) :1548 - 55.
[ 30 ] Saha A K, Avilucea P R, Ye JM, et al. Pioglitazone treatment activatesAMP2activated p rotein kinase in rat liver and adipose tissue in vivo[ J ]. Biochemical & Biophysical Research Communications,2004, 314 (2) : 580 - 5.
[ 31 ] Fryer L G, Parbu2Patel A, CarlingD. The anti2diabetic drugs rosiglitazone and metformin stimulate AMP2activated p rotein kinase through distinct signaling pathways [ J ]. J B iol Chem, 2002, 277(28) : 25226 - 32.
[ 32 ] Yu X, McCorkle S, WangM, et al. Lep tinomimetic effects of the AMP kinase activatorA ICAR in lep tin2resistant rats: p revention of diabetes and ectop ic lip id deposition [ J ]. D iabetologia, 2004, 47(11) : 2012 - 21.
[ 33 ] 　Hwang J T, Park I J. Shin J I, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation p rocess via activating AMPactivated p rotein kinase[ J ]. B iochem B iophys Res Comm un, 2005,338 (2) : 694 - 9.
[ 34 ] 　Misra P, Chakrabarti R. The role ofAMP kinase in diabetes[ J ].Indian J M ed Res, 2007, 125 (3) : 389 - 98.